1-8 of 8
Hans-Jörg Bühring
Close
Sort by
Journal Articles

Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML

Anudishi Tyagi, Stanley Ly, Fouad El-Dana, Bin Yuan, Appalaraju Jaggupilli, Sabrina Grimm, Marina Konopleva, Hans-Jörg Bühring, V. Lokesh Battula
Journal: Blood
Blood (2022) 139 (18): 2782–2796.
https://doi.org/10.1182/blood.2021014671
Published: 2022
Includes: Supplemental data
Journal Articles

Anti-B7-H3 Antibody (T-1A5) Blocks Immunomodulatory Function of B7-H3 and Enhances NK Cell-Mediated Cytotoxicity Against Acute Myeloid Leukemia Cells

Anudishi Tyagi, Stanley Ly, Fouad El-Dana, Bin Yuan, Sabrina Grimm, Hans-Jörg Bühring, Venkata Lokesh Battula
Journal: Blood
Blood (2021) 138 (Supplement 1): 3336.
https://doi.org/10.1182/blood-2021-151535
Published: 2021
Journal Articles

Induction of NK Cell Reactivity Against Myeloid Leukemia By a Novel Fc-Optimized CD133 Antibody

Kathrin Rothfelder, Samuel Koerner, Maya Andre, Julia Leibold, Philaretos Kousis, Hans-Jörg Bühring, Sebastian P. Haen, MD, Ayline Kuebler, Lothar Kanz, MD, Ludger Grosse-Hovest, Gundram Jung, Helmut R Salih, MD
Journal: Blood
Blood (2015) 126 (23): 3793.
https://doi.org/10.1182/blood.V126.23.3793.3793
Published: 2015
Journal Articles

Both mature KIR + and immature KIR − NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdc scid IL2rg tmWjl /Sz mice

Ayline Kübler, Jeanette Woiterski, Kai-Erik Witte, Hans-Jörg Bühring, Udo F. Hartwig, Martin Ebinger, Lena Oevermann, Markus Mezger, Wolfgang Herr, Peter Lang, Rupert Handgretinger, Christian Münz, Maya C. André
Journal: Blood
Blood (2014) 124 (26): 3914–3923.
https://doi.org/10.1182/blood-2014-05-572743
Published: 2014
Includes: Supplemental data
Journal Articles

The Innate Immune System Favors Emergency Monopoiesis at the Expense of DC Differentiation to Control Bacterial Infections

Kristin Bieber, Karina A. Pasquevich, Manina Günter, Matthias Grauer, Oliver Pötz, Ulrike Schleicher, Tilo Biedermann, Sandra Beer-Hammer, Hans-Jörg Bühring, Hans-Georg Rammensee, PhD, Lars Zender, Ingo B. Autenrieth, Lothar Kanz, MD, Claudia Lengerke, Stella E. Autenrieth
Journal: Blood
Blood (2014) 124 (21): 2722.
https://doi.org/10.1182/blood.V124.21.2722.2722
Published: 2014
Journal Articles

Novel Markers for the Isolation of Primary Bone Marrow Derived MSC with Multi-Lineage Differentiation Capacity.

Hans-Jorg Buhring, PhD, Venkata L. Battula, MS, Sabrina Treml, Lothar Kanz, M.D., Wichard Vogel, M.D.
Journal: Blood
Blood (2006) 108 (11): 2573.
https://doi.org/10.1182/blood.V108.11.2573.2573
Published: 2006
Journal Articles

Prospective Isolation of Mesenchymal Stem Cells from Human Bone Marrow and Placenta Using a Frizzled-9-Specific Monoclonal Antibody.

Venkata L. Battula, MS, Sabrina Treml, Lothar Kanz, M.D., Hans-Jorg Buhring, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2557.
https://doi.org/10.1182/blood.V108.11.2557.2557
Published: 2006
Journal Articles

Increased Recruitment of Hematopoietic Progenitor Cells Underlies the Ex Vivo Expansion Potential of FLT3 Ligand

David N. Haylock, Martyn J. Horsfall, Tracey L. Dowse, Hayley S. Ramshaw, Silvana Niutta, Sandra Protopsaltis, Li Peng, Christopher Burrell, Irene Rappold, Hans-Jorg Buhring, Paul J. Simmons
Journal: Blood
Blood (1997) 90 (6): 2260–2272.
https://doi.org/10.1182/blood.V90.6.2260
Published: 1997